3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Vaginal Neoplasms
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroendocrine Tumors
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Gallbladder Neoplasms
1
Blast Crisis
1
Interventions
Tretinoin
5
Methotrexate
5
Tacrolimus
4
Arsenic Trioxide
4
fludarabine phosphate
3
Peripheral Blood Stem Cell Transplantation
3
Busulfan
3
Mycophenolic Acid
2
Mercaptopurine
2
Idarubicin
2
Gemtuzumab
2
Filgrastim
2
Cytarabine
2
Cyclophosphamide
2
Antilymphocyte Serum
2
thymoglobulin
1
entinostat
1
Whole-Body Irradiation
1
Vorinostat
1
Sorafenib
1
Sirolimus
1
Granulocyte Colony-Stimulating Factor
1
Erlotinib Hydrochloride
1
Daunorubicin
1
Clofarabine
1
Bortezomib
1
Biopsy
1
Azacitidine
1
Alemtuzumab
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Promyelocytic, Acute
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
Clear all
No trials found.